Quintela Fandiño, Miguel Angel miguel.quintela@uam.es
Actividades
- Artículos 52
- Libros 0
- Capítulos de libro 0
- Congresos 1
- Documentos de trabajo 0
- Informes técnicos 1
- Proyectos de investigación 0
- Tesis dirigidas 1
- Patentes o licencias de software 0
DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy
- Quintela-Fandino, Miguel
- Hitt, Ricardo
- Medina, Pedro P.
- Gamarra, Soledad
- Manso, Luis
- Cortes-Funes, Hernan
- Sanchez-Cespedes, Montserrat;
Journal Of Clinical Oncology (p. 4333-4339) - 10/9/2006
10.1200/jco.2006.05.8768 Ver en origen
- ISSN 0732183X
DOVITINIB LACTATE Multikinase Inhibitor Antiongiogenic Agent Oncolytic
- Quintela-Fandino
- M Colomer
- R
Drugs Of The Future (p. 81-89) - 1/1/2013
10.1358/dof.2013.38.2.1918242 Ver en origen
- ISSN 03778282
Differential requirement of MALT1 for BAFF-induced outcomes in B cell subsets
- Tusche, Michael W.
- Ward, Lesley A.
- Vu, Frances
- McCarthy, Doug
- Quintela-Fandino, Miguel
- Ruland, Jurgen
- Gommerman, Jennifer L.
- Mak, Tak W.;
Journal Of Experimental Medicine (p. 2671-2683) - 23/11/2009
10.1084/jem.20091802 Ver en origen
- ISSN 00221007
Emerging role of Fatty acid synthase in tumor initiation: implications for cancer prevention
- Bueno MJ
- Quintela-Fandino M
Mol Cell Oncol - 3/3/2020
10.1080/23723556.2019.1709389 Ver en origen
- ISSN 23723556
Essentiality of fatty acid synthase in the 2D to anchorage-independent growth transition in transforming cells
- Bueno, Maria J.
- Jimenez-Renard, Veronica
- Samino, Sara
- Capellades, Jordi
- Junza, Alejandra
- Luz Lopez-Rodriguez, Maria
- Garcia-Carceles, Javier
- Lopez-Fabuel, Irene
- Bolanos, Juan P.
- Chandel, Navdeep S.
- Yanes, Oscar
- Colomer, Ramon
- Quintela-Fandino, Miguel;
Nature Communications (p. 1-18) - 1/12/2019
10.1038/s41467-019-13028-1 Ver en origen
- ISSN 20411723
- iMarina
- iMarina
F-18-fluoromisonidazole PET and Activity of Neoadjuvant Nintedanib in Early HER2-Negative Breast Cancer: A Window-of-Opportunity Randomized Trial
- Quintela-Fandino, M.
- Lluch, A.
- Manso, L.
- Calvo, I.
- Cortes, J.
- García-Saenz, J.A.
- Gil-Gil, M.
- Martinez-Jánez, N.
- Gonzalez-Martin, A.
- Adrover, E.
- De Andres, R.
- Viñas, G.
- Llombart-Cussac, A.
- Alba, E.
- Guerra, J.
- Bermejo, B.
- Zamora, E.
- Moreno-Anton, F.
- Simon, S.P.
- Carrato, A.
- Lopez-Alonso, A.
- Escudero, M.J.
- Campo, R.
- Carrasco, E.
- Palacios, J.
- Mulero, F.
- Colomer, R.
Clinical Cancer Research (p. 1432-1441) - 15/3/2017
Editor: American Association for Cancer Research Inc.
10.1158/1078-0432.ccr-16-0738 Ver en origen
- ISSN 15573265
- ISSN/ISBN 1557-3265
FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1
- Mouron S, Manso L, Caleiras E, Rodriguez-Peralto JL, Rueda OM, Caldas C, Colomer R, Quintela-Fandino M, Bueno MJ
Breast Cancer Research (p. 21-21) - 1/12/2021
- ISSN 14655411
- iMarina
Glutamine-Directed Migration of Cancer-Activated Fibroblasts Facilitates Epithelial Tumor Invasion
- Mestre-Farrera A
- Bruch-Oms M
- Peña R
- Rodríguez-Morato J
- Alba-Castellon L
- Comerma L
- Quintela-Fandino M
- Duñach M
- Baulida J
- Pozo OJ
- de Herreros AG
Cancer Research (p. 438-451) - 15/1/2021
10.1158/0008-5472.can-20-0622 Ver en origen
- ISSN 00085472
HUNK suppresses metastasis of basal type breast cancers by disrupting the interaction between PP2A and cofilin-1
- Quintela-Fandino, Miguel
- Arpaia, Enrico
- Brenner, Dirk
- Goh, Theo
- Yeung, Faith Au
- Blaser, Heiko
- Alexandrova, Roumiana
- Lind, Evan F.
- Tusche, Mike W.
- Wakeham, Andrew
- Ohashi, Pamela S.
- Mak, Tak W.;
Proceedings Of The National Academy Of Sciences Of The United States Of America (p. 2622-2627) - 9/2/2010
10.1073/pnas.0914492107 Ver en origen
- ISSN 10916490
Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trial
- Quintela-Fandino M
- Holgado E
- Manso L
- Morales S
- Bermejo B
- Colomer R
- Apala JV
- Blanco R
- Muñoz M
- Caleiras E
- Iranzo V
- Martinez M
- Dominguez O
- Hornedo J
- Gonzalez-Cortijo L
- Cortes J
- Gasol Cudos A
- Malon D
- Lopez-Alonso A
- Moreno-Ortíz MC
- Mouron S
- Mañes S
Breast Cancer Research - 1/12/2020
10.1186/s13058-020-01362-y Ver en origen
- ISSN 14655411
Este/a investigador/a no tiene libros.
Este/a investigador/a no tiene capítulos de libro.
Phase I clinical trial of neoadjuvant BIBF1120 plus weekly paclitaxel (P) in early HER-2 negative breast cancer. CNIO-BR-01-2010 GEICAM 2010-10 study
- Quintela-Fandino, M.
- Urruticoechea, A.
- Guerra, J.
- Gil, M.
- Gonzalez-Martin, A.
- Marquez, R.
- Hernandez-Agudo, E.
- Rodriguez-Martin, C.
- Gil, M.
- Bratos, R.
- Escudero, M. J.
- Colomer, R.;
Cancer Research - 15/12/2013
10.1158/0008-5472.sabcs13-pd5-8 Ver en origen
- ISSN 00085472
Este/a investigador/a no tiene documentos de trabajo.
A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3K?/?, in Patients with Advanced Solid Tumors
- Choudhury AD, Higano CS, de Bono JS, Cook N, Rathkopf DE, Wisinski KB, Martin-Liberal J, Linch M, Heath EI, Baird RD, García-Carbacho J, Quintela-Fandino M, Barry ST, de Bruin EC, Colebrook S, Hawkins G, Klinowska T, Maroj B, Moorthy G, Mortimer PG, Moschetta M, Nikolaou M, Sainsbury L, Shapiro GI, Siu LL, Hansen AR
Clinical Cancer Research (p. 2257-2269) - 1/1/2022
10.1158/1078-0432.ccr-21-3087 Ver en origen
- ISSN 15573265
Este/a investigador/a no tiene proyectos de investigación.
Este/a investigador/a no tiene patentes o licencias de software.
Perfiles de investigador/a
-
ORCID
-
Scopus Author ID
-
Dialnet id